Illumina, headquartered in San Diego, develops life science tools for genetic analysis, employing 10,590 staff since its IPO in 2000. Its products span various applications, including oncology and agriculture.
ILMN has been in the news recently: Illumina, Inc. has introduced a 5-base solution that allows for the simultaneous detection of genomic variants and DNA methylation, improving precision medicine for rare diseases and cancer. Additionally, Illumina's constellation technology, tested by GeneDx on 160 DNA samples, has shown superior performance in identifying challenging variants compared to traditional methods.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.